Clinical Efficacy of Ertapenem for Recurrent Cystitis Caused by Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli in Female Outpatients.

CONCLUSIONS: Parenteral ertapenem treatment can be an effective and well-tolerated treatment option for intractable recurrent cystitis by multidrug-resistant ESBL-producing E. coli. PMID: 24741417 [PubMed]

http://www.ncbi.nlm.nih.gov/pubmed/24741417?dopt=Abstract

Source: Korean Journal of Urology - December 1, 2014 Category: Urology & Nephrology Tags: Korean J Urol Source Type: research